From: Promoting independence in Lewy body dementia through exercise: the PRIDE study
n = 9 | |||||
---|---|---|---|---|---|
Age (years) | 74 | (66–84) | |||
Sex (male), n | 7 | ||||
Ethnicity (Caucasian), n | 8 | ||||
Body Mass Index (BMI), kgm−2 | 24.9 | (21.0–26.3) | |||
Diagnosis (PDD/DLB), n | 5 / 4 | ||||
Time since diagnosisa, months | 12 | (3–48) | |||
Visits required for diagnosisb, n | 3 | (1–7) | |||
MDS-UPDRS total score, /260 | 86 | (57–169) | |||
Part III motor—sub score, /132 | 46 | (33–82) | |||
Clinical dementia rating (CDR) scorec, /3 | |||||
Mild (1), n | 5 | ||||
Moderate (2), n | 2 | ||||
Severe (3), n | 2 | ||||
FIM total score, /126 | 102 | (30–122) | |||
MMSE total score, /30 | 22 | (5–29) | |||
PD-CRS total score, /134 | 44 | (7–83) | |||
GDS–15 total score, /15 | 1 | (0–3*) | |||
Reported falls in prior yeard, n | 2 | (0–20) | |||
Injurious falls requiring hospitalization e, n | 5 | ||||
Recurrent fallers (≥ 2 falls in last year) f, n | 6 | ||||
Diagnosed comorbidities g, n | 5 | ||||
Prescribed medications h, n | 5 | ||||
Participants with: | |||||
≥ 5 medications prescribed (polypharmacy), n | 6 | ||||
Anticholinergic Burden (ACB) score ≥ 3, n | 2 | ||||
Potentially inappropriate medications (PIMs), n | 5 | ||||
Medication class (number of participants taking ≥ 1 medication in each class) | |||||
Dopaminergic, n | 7 | Anti-platelet, Anti-coagulant, n | 3 | ||
Neuroleptic, n | 2 | Statins, n | 3 | ||
Sedative/Tranquilizer, n | 2 | Blood pressure regulating, n | 4 | ||
Antidepressant, n | 4 | PPI, n | 2 | ||
AChEI, /NMDA receptor agonist, n | 5 | Supplements, n | 4 |